EGFR-INHIBITOREN
European patent · EP4076664 · In force
Register entry
- Publication number
- EP4076664
- Application number
- EP20833855
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 18, 2020
- Published
- Oct 26, 2022
- Granted
- Aug 30, 2023
- Protection ends at the latest
- Dec 17, 2040
- Next annual fee due
- Dec 31, 2026
- IPC classes
- A61P 35/00 (2006.01)C07D 487/04 (2006.01)A61K 31/454 (2006.01)
- Priority
- EP 19218403 20.12.2019
- PCT application
- PCT/EP2020/086914 18.12.2020
- PCT publication
- WO2021/123084 24.06.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Jul 10, 2024
Change
Published in Swissreg on 10.07.2024
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Aug 30, 2023
Granted
Published in Swissreg on 30.08.2023
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.